Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib Trial of HER2/Neu Peptide (E75) Vaccine in Node Negative Breast Cancer Patients

NCT00854789 is registered in ClinicalTrials.gov with COL George Peoples, MD, FACS as lead sponsor.

NCT NCT00854789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00854789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib Trial of HER2/Neu Peptide (E75) Vaccine in Node Negative Breast Cancer Patients
Lead sponsor
COL George Peoples, MD, FACS
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2002
Completion date
March 31, 2013
Enrollment
95 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer